| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |